Online HML - May 2022


You are viewing May 2022. View April 2022 Schedule.

Nucleoside Reverse Transcriptase Inhibitors

Efavirenz with emtricitabine and tenofovir disoproxil         

/\ Tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a maleate) - 1% DV Jun-19 to 2022 (HSS)

Mylan 2558505 $106.88 per 30

Nucleoside Reverse Transcriptase Inhibitors

Emtricitabine         

/\ Cap 200 mg - 1% DV Jul-19 to 2022 (HSS)

Emtriva 2250063 $307.20 per 30

HIV Prophylaxis and Treatment

Emtricitabine with tenofovir disoproxil         

/\ Tab 200 mg with tenofovir disoproxil 245 mg (300.6 mg as a succinate) - 1% DV Jun-19 to 2022 (HSS)

Teva 2560488 $61.15 per 30